Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
Digestive Diseases and Sciences|July 28, 2011
Endoscopic findings and clinical outcomes in ventricular assist device recipients with gastrointestinal bleedingB J Elmunzer, B Joseph Elmunzer, Kunjali T Padhya, et al.
The American Journal of Gastroenterology|February 24, 2006
Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitorsJames M Scheiman, Neville D Yeomans, Nicholas J Talley, et al.
Electrophoresis|July 7, 2011
A multiplexed bead assay for profiling glycosylation patterns on serum protein biomarkers of pancreatic cancerChen Li, Eugene Zolotarevsky, Ian Thompson, et al.
Journal of Proteome Research|March 23, 2011
Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancerZhenxin Lin, Diane M Simeone, Michelle A Anderson, et al.
Journal of Proteome Research|March 4, 2015
Large-scale identification of core-fucosylated glycopeptide sites in pancreatic cancer serum using mass spectrometryZhijing Tan, Haidi Yin, Song Nie, et al.
The Journal of Rheumatology|November 4, 2009
A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tractFrancis K L Chan, Byron Cryer, Jay L Goldstein, et al.
Surgical Innovation|May 28, 2010
Hydroperitoneum-facilitated EUS-guided peritoneal entry and closure of alternate access sites for NOTESB Joseph Elmunzer, Amitabh Chak, Jason R Taylor, et al.
Critical Pathways in Cardiology|July 30, 2013
Evaluation and management of the atrial fibrillation patient: a report from the Society of Cardiovascular Patient CareBenjamin A Steinberg, Philip D Beckley, Thomas F Deering, et al.
Annals of Surgery|April 17, 2010
Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasmsBrian B Haab, Andrew Porter, Tingting Yue, et al.
Pageof 16